Tanner Johanns, MD, PhD

Medical Oncologist

Tanner Johanns

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Clinical Expertise

  • Skin cancer, brain tumors

Primary Academic Title

Assistant Professor of Medicine, Division of Medical Oncology, WashU Medicine

Board Certification

  • 2015: American Board of Internal Medicine
  • 2018: American Board of Medical Oncology

Training

  • 2012 - 2013: Intern, Internal Medicine, Barnes-Jewish Hospital, St. Louis, MO
  • 2013 - 2014: Resident, Internal Medicine, Barnes-Jewish Hospital, St. Louis, MO
  • 2014 - 2015: Fellow, Medical Oncology, Washington University, St. Louis, MO
  • 2015 - 2018: Research Fellow, Hematology, Washington University, St. Louis, MO

Education

  • 2012: MD/PhD, University of Minnesota, Minneapolis, MN

Research & Selected Publications

Research Publications

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Authors:

Garfinkle EAR, Perales-Linares R, Gimple RC, one or more additional authors omitted Johanns TM

Journal & Year:

Nat Cancer | 2026

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial
Authors:

Campian JL, Le SB, Ghiaseddin A, one or more additional authors omitted Johanns T, one or more additional authors omitted Tran DD

Journal & Year:

Nat Commun | 2026

Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Authors:

Johanns TM, Garfinkle EAR, Miller KE, one or more additional authors omitted Dunn GP

Journal & Year:

Clin Cancer Res | 2024

Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Authors:

Wang AZ, Mashimo BL, Schaettler MO, one or more additional authors omitted Johanns TM, Dunn GP

Journal & Year:

Cancer Discov | 2024